Bruno Mourvillier, MD, Medical Intensive Care Unit, University Hospital of Reims, Reims, France
Friday, October 21, 2022
1:55 to 2:05 pm ET US
"Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab’s Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia"
<< back to list